We compared the expression levels of FLT3 and Bcl-2 in THP-1 cells with those of primary leukemic cells isolated from chemotherapy R/R AML patients to consider the clinical relevance on the expression levels. The gene discussed is BCL2; the disease is acute myeloid leukemia.